Bempedoic acid
Esperion
['erda']
yesterday shared results of our #clearoutcomes trial at #acc23/wcc. women made up 48% of enrollment compared to 24-38% in other cvot studies. proud to work for a company that "walks the talk" when it comes to representation in clinical trials. 
CMO Esperion, A Passion for Prevention, Champion for Women’s Health/ ❤️ Doc, #CVPrevention #WIC